Have you or your loved ones been diagnosed with solid tumors?

You may be eligible to participate in a solid tumors clinical trial.

Have you or your loved ones been diagnosed with solid tumors? You may be eligible to participate in a solid tumors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Solid Tumors Clinical Trial in San Francisco CA
NCT02240238 | Phase 1 phase 2 | Interventional
NanoCarrier Co Ltd
Sponsored by
NanoCarrier Co Ltd

Have you or your loved ones been diagnosed with solid tumors?

You may be eligible to participate in a solid tumors clinical trial.

Have you or your loved ones been diagnosed with solid tumors? You may be eligible to participate in a solid tumors clinical trial.

Completed

Male & Female

18 Years +

This study is looking to recruit 209 Participants

In the dose escalation phase (Part 1), this study will determine the dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD) and recommended Phase 2 (RPII) dose of NC 6004 in combination with gemcitabine. In the expansion phase of the study (Part 2), study will evaluate the activity, safety, and tolerability at the RPII dose identified in Part 1 in patients with squamous NSCLC, biliary tract, and bladder cancer.